Список литературы

Поставить закладку

Howick JH. The Philosophy of Evidence-based Medicine. Wiley. p. 15.
Sackett DL, Rosenberg WM, Gray JA, et al. Evidence based medicine: what it is and what it isn’t. BMJ.1996;312:71–72.
Федеральный закон от 21.11.2011 № 323-ФЗ (ред. от 03.04.2017) «Об основах охраны здоровья граждан в Российской Федерации».
Андреева Н.С., Реброва О.Ю., Зорин Н.А. Системы оценки достоверности научных доказательств и убедительности рекомендаций: сравнительная характеристика и перспективы унификации. // Медицинские технологии. Оценка и выбор. — 2012. — № 4. — С. 10–24.
Макаров Л.М..Холтеровскоемониторирование. 4-е изд. – М.: ИЖ «Медпрактика-М»-2017.-504 с.
Аритмии сердца: Механизмы, диагностика, лечение: Монография: В 3 т (под ред. МанделаВ.Дж. / пер. с англ. – М.: Медицина, 1996. – Т. 2. – 464 с.
Белозеров Ю.М. Детская кардиология. – МЕДпрес-информ, 2004. –525c
Егоров Д.Ф., Адрианов А.В.. Диагностика и лечение брадикардии у детей. – СПб.: «Человек», 2008. – 320 с.
Fetal Cardiology: Embryology, Genetics, Physiology, Echocardiographic Evaluation, Diagnosis and Perinatal Management of Cardiac Diseases.Third Edition. SimchaYagel, Norman H. Silverman, Ulrich Gembruch - Taylor & Francis Group, LLC, 2019. – 860 p.
BrucatoA. Prevention of congenital heart block in children of SSA-positive mothers //Rheumatology. – 2008. – Vol. 47, suppl 3. – P. 35–37.
Brucato A., Jonson A., Friedmen D. et al. Proposal for a new definition of congenital complete atrioventricular block // Lupus. – 2003. – Vol. 12 (6). – P. 425–426.
Clancy R.M., Kapur R.P., Buyon J.P. et al. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage ,fibroblast crosstalk in the pathologic cascade leading to congenital heart block // Arthritis Rheum.2004;50:173-182
Edward P., Walsh J., Philip Saul et al. Cardiac arrhythmias in children and young adults with congenital heart disease. – LippricontWilliams&Wilkins, 2001. – 516 p.
Hung D. Allen et al. Moss and Adams. Heart disease in infants, children, and adolescents: including the fetus and young adult. 7th ed. – LippricontWilliams&Wilkins, 2008. – Vol. 1. – 760 p.
Park Myung K. Pediatric Cardiology for Practitioners. 7 th ed. – Elsevier, 2021. – 487 p.
Zeigler V.L., Gillette P.G..Practical management of pediatric cardiac arrhytmias. – Futura Publishing Company, Inc. Armonk, NY, 2001. – 422 p.
Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Brugada J, Blom N, Sarquella-Brugada G, Blomstrom-Lundqvist C, Deanfield J, Janousek J, Abrams D, Bauersfeld U, Brugada R, Drago F, de Groot N, Happonen JM, Hebe J, Yen Ho S, Marijon E, Paul T, Pfammatter JP, Rosenthal E; European Heart Rhythm Association; Association for European Paediatric and Congenital Cardiology.Europace.2013 Sep;15(9):1337-82.
Alboni P, Anna Holz, Michele Brignole. Vagally mediated atrioventricular block: pathophysiology and diagnosis. Heart.2013;99:904–908.
Ambrosi A, Wahren-Herlenius M Congenital heart block: evidence for a pathogenic role of maternal autoantibodies. Arthritis Res Ther. 2012;14:208.
Perinatal Outcome in Fetuses with Heterotaxy Syndrome and Atrioventricular Block or Bradycardia Maria C. Escobar-Diaz, Wayne Tworetzky, Kevin Friedman, Terra Lafranchi, Francis Fynn-Thompson, Mark E. Alexander, and Douglas Y. MahPediatrCardiol. 2014 Aug;35(6):906–913.
Andrea W Wan, Alexandra Jevremovic, ElifSedaSelamet Tierney, Brian W McCrindle, Elizabeth Dunn, Cedric Manlhiot, Rachel M Wald, John P Kingdom, Edgar T Jaeggi, Lynne E Nield. Comparison of impact of prenatal versus postnatal diagnosis of congenitally corrected transposition of the great arteries. Am J Cardiol. 2009 Nov1;104(9):1276-9.
Antoon F M Moorman, Vincent M Christoffels, Robert H Anderson. Anatomic substrates for cardiac conduction. Heart Rhythm.2005Aug;2(8):875-86.
Susan P Etheridge, Hitoshi Horigome, Denver Sallee, Anita Moon-Grady, Hsin-Yi Weng, Michael J Ackerman, D Woodrow Benson. Arrhythmia phenotype during fetal life suggests long-QT syndrome genotype: risk stratification of perinatal long-QT syndrome. CircArrhythmElectrophysiol.2013Oct;6(5):946-51
J P Buyon, R Hiebert, J Copel, J Craft, D Friedman, M Katholi, L A Lee, T T Provost, M Reichlin, L Rider, A Rupel, S Saleeb, W L Weston, M L Skovron. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. Am CollCardiol. 1998;31:1658–66
Baruteau AE, Fouchard S, Behaghel A, Mabo P, Villain E, Thambo JB, Marçon F, Gournay V, Rouault F, Chantepie A, Guillaumont S, Godart F, Bonnet C, Fraisse A, Schleich JM, Lusson JR, DulacY,Leclercq C, Daubert JC, Schott JJ, Le Marec H, ProbstV Characteristics and long-term outcome of nonimmune isolated atrioventricular block diagnosed in utero or early childhood: amulticentre study. Eur Heart J. 2012; 33:622–629;
Bettina F Cuneo, Susan P Etheridge, Hitoshi Horigome, Denver Sallee, Anita Moon-Grady, Hsin-Yi Weng, Michael J Ackerman, D Woodrow Benson. Arrhythmia phenotype during fetal life suggests long-QT syndrome genotype: risk stratification of perinatal long-QT syndrome. CircArrhythmElectrophysiol. 2013 Oct;6(5):946-51
Liberman L, Silver ES, Chai P, Anderson BR (2016) Incidence and characteristics of heart block after heart surgery in pediatric patients: a multicenter study. J ThoracCardiovasc Surg.2016 Jul;152(1):197-202.
Кошелева Н.М., Алекберова З.С. Неонатальная волчанка // Современная ревматология. — 2015. — Т.9. — №4 —С. 92–97.
Fred M. Kusumoto, Chair, Mark H. Schoenfeld, Vice Chair, Coletta Barrett, James R. Edgerton, Kenneth A. Ellenbogen, Michael R. Gold, Nora F. Goldschlager, Robert M. Hamilton, José A. Joglar, Robert J. Kim, Richard Lee, Joseph E. Marine, Christopher J. McLeod, Keith R. Oken, Kristen K. Patton, Cara N. Pellegrini, Kimberly A. Selzman, Annemarie Thompson, and Paul D. Varosy. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. CirculationVolume 140, Issue 8, 20. August 2019;382-482
Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). European Heart Journal. 2013;34:2281–2329;
Del Rosso A, Ungar A, Maggi R, et al. Clinical predictors of cardiac syncope at initial evaluation in patients referred urgently to a general hospital: the EGSYS score. Heart. 2008;94:1620–6;
Perez-Rodon J, Martinez-Alday J, Baron-Esquivias G, et al. Prognostic value of the electrocardiogram in patients with syncope: data from the group for syncope study in the emergency room (GESINUR). Heart Rhythm. 2014;11:2035–44;
Shen WK, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2017;136:60–122
Wan, D, Blakely, C, Branscombe, P, et al. Lyme carditis and high-degree atrioventricular block. Am J Cardiol. 2018;121:1102–4
Mandell, BF. Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum. 1987;17:126–41.
Nakayama, Y, Ohno, M, Yonemura, S, et al. A case of transient 2:1 atrioventricular block, resolved by thyroxine supplementation for subclinical hypothyroidism. Pacing ClinElectrophysiol. 2006;29:106–8
Brubaker, PH, Kitzman, DW. Chronotropic incompetence: causes, consequences, and management. Circulation. 2011;123:1010–20
Fouron JC, ProulxF,MiroJ,Gosselin J Doppler and M-mode ultrasonography to time fetal atrial and ventricular contractions. Obstet Gynecol. 2000; 96:732–6.
Ostensen M., Khamashta M., Lockshin M. et al. Anti-inflammatory and immunosuppressive drugs and reproduction // Arthritis Res. Ther. 2006. – Vol. 8. – 209 p.
Ruffatti A, Milanesi O, Chiandetti L, Cerutti A, Gervasi MT, De Silvestro G, Pengo V, Punzi L. A combination therapy to treat second-degree anti-Ro/La-related congenital heart block: a strategy to avoid stable third-degree heart block? // Lupus. 2012 May; 21(6):666-71.
Amit Saxena, Peter M. Izmirly, Barbara Mendez, Jill P. Buyon, Deborah M. Friedman. Prevention and treatment in utero of autoimmune associated congenital heart block // Cardiol Rev. 2014;22(6): 263–267.
Jaeggi ET, Fouron JC, Silverman ED, Ryan G, Smallhorn J, Hornberger LK Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation. 2004;110:1542–8;
Zhao H, Cuneo BF, Strasburger JF, Huhta JC, Gotteiner NL, Wakai RT. Electrophysiological characteristics of fetal atrioventricular block. J Am CollCardiol. 2008; 51:77–84
Skog A, Wahren-Herlenius M, Sundstrom B, Bremme K, Sonesson SE. Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies. Pediatrics 2008;121:803–9.
Friedman DM, Llanos C, Izmirly PM, Brock B, Byron J, Copel J, Cummiskey K, Dooley MA, Foley J, Graves C, Hendershott C, Kates R, Komissarova EV, Miller M, Paré E, Phoon CK, Prosen T, Reisner D, Ruderman E, Samuels P, Yu JK, Kim MY, Buyon JP Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial. Arthritis Rheum. 2010; 62:1138–46
Cuneo BF, Lee M, Roberson D, Niksch A, Ovadia M, Parilla BV, Benson DW A management strategy for fetal immunemediatedatrioventricular block. J Matern Fetal Neonatal Med. 2010; 23: 1400–5
Schmidt KG, Ulmer HE, Silverman NH, Kleinman CS, Copel JA Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. J Am CollCardiol. 1991; 17:1360–6
Liberman L, Pass RH, Hordof AJ, SpotnitzHM Late onset of heart block after open heart surgery for congenital heart disease. PediatrCardiol. 2008; 29:56–9;
LotfyW, Hegazy R, Abdelaziz O, Sobhy R, Hasanein H, Shaltout F Permanent cardiac pacing in pediatric patients. PediatrCardiol. 2013; 34:273–280
Ashok P. Sarnaik • Robert D. Ross Steven E. Lipshultz • Henry L. Walters III .Cardiac Emergencies in Children. A Practical Approach to Diagnosis and Management. - Springer International Publishing AG, part of Springer Nature, 2018.-400 p;
Brady WJ, Swart G, DeBehnke DJ, et al. The efficacy of atropine in the treatment of hemodynamically unstable bradycardia and atrioventricular block: prehospital and emergency department considerations. Resuscitation. 1999;41:47–55.
Henry M. Spotnitz, MD. Transvenous Pacing in Infants and Children With Congenital Heart Disease. Ann ThoracSurg 1990;49:495-6;
Robert Whitehill, Peter Fischbach, Jessica Posey, ^† Fawwaz Shaw, and Chad Mao, Temporary transvenous atrioventricular synchronous pacing using a single lead in a pediatric patient. HeartRhythm Case Rep. 2019 Dec; 5(12): 593–596;
Murphy JJ. Current practice and complications of temporary transvenous cardiac pacing. BMJ.1996;312:1134
Michele Brignole, Angelo Auricchio, Gonzalo Baron-Esquivias, PierreBordachar, Giuseppe Boriani, Ole-A Breithardt, John Cleland, Jean-Claude Deharo, Victoria Delgado, Perry M.Elliott, BulentGorenek, CarstenW. Israel, Christophe Leclercq, Cecilia Linde, Lluı ´sMont, Luigi Padeletti, Richard Sutton, PanosE.Vardas/ 2013 ESC Guidelines сardiac pacing and cardiac resynchronization therapy // European Heart Journal. 2013. – Vol. 34 – P. 2281-2329.
Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NA 3rd, Ferguson TB Jr, Hammill SC, Karasik PE, Link MS, Marine JE, Schoenfeld MH, Shanker AJ, Silka MJ, Stevenson LW, Stevenson WG, Varosy PD ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the HeartRhythm Society. JAmCollCardiol. 2013 Jan 22;61(3):e6-75.
Minimally Invasive Epicardial Pacemaker Implantation in Neonates with Congenital Heart Block. R. Costa, K. R da Silva, M. M.iFilho, R. Carrillo. Arq Bras Cardiol. 2017;109(4):331-339.
Alban-ElouenBaruteau, R H. Pass, JB Thambo, A Behaghe, S Le Pennec, E Perdreau, N Combes, L Liberman, C J. McLeod. Congenital and childhood atrioventricular blocks: pathophysiology and contemporary management Eur J Pediatr. 2016; 175:1235–1248
M S Horenstein, P PKarpawich, M V Tantengco. Single versus dual chamber pacing in the young: noninvasive comparative evaluation of cardiac function.Pacing ClinElectrophysiol. 2003 May;26(5):1208-11
Janoušek J., van Geldorp I.E.,Krupičková S., Rosenthal E., Nugent K., Tomaske M., Früh A., Elders J., Hiippala A., Kerst G., Gebauer R.A., Kubuš P., Frias P., Gabbarini F., Clur S-A., Nagel B., Ganame J., Papagiannis J., Marek J., Tisma-Dupanovic S., Tsao S., Nürnberg J-H., Wren Ch., Friedberg M., de Guillebon M., Volaufova J., Prinzen F.W., Delhaas T. Permanent cardiac pacing in children: choosing the optimal pacing site: a multicenter study. Circ. 2013;127(5):613-623.
Left ventricular apical pacing in children: feasibility and long-termeffect on ventricular function. J Kovanda ,M.Lozek, S Ono, P. Kubus, V Tomek, J Janousek. Europace 2020; 22:306–313
Carreras EM, Duncan WJ, Djurdjev O, Campbell AI. Cardiac strangulation following epicardial pacemaker implantation: a rare pediatric complication. J ThoracCardiovasc Surg. 2015;149(2):522-27.
Takeuchi D, Tomizawa Y. Cardiac strangulation from epicardial pacemaker leads: diagnosis, treatment, and prevention. Gen ThoracCardiovasc Surg. 2015;63(1):22-9.
Slotwiner D, Varma N, Akar JG, et al. Совместное экспертное заключение Американскогообщества сердечного ритма (HRS) по удаленной телеметрии и мониторингу сердечно-сосудистых имплантируемых электронных устройств. // Вестник аритмологии. — 2015. —№82. — С. 43–72.
Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 9: arrhythmias and conduction defects: a scientific statement from the American Heart Association and American College of Cardiology. Zipes DP, Link MS, Ackerman MJ, et al. J Am CollCardiol. 2015;66(21):2412–2423.